Linagliptin and Mesenchymal Stem Cells: A Pilot Study
Status:
Completed
Trial end date:
2018-03-02
Target enrollment:
Participant gender:
Summary
The purpose of the present study is to gather pilot data on the effects of linagliptin on the
concentration of the long and short forms of SDF1-α (stromal cell-derived factor alpha) in
humans, and to demonstrate the feasibility of such a study in patients with psychosis in our
setting.